약학회지
YAKHAK HOEJI
ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)

Table. 5.

Table. 5.

Cost and utilization trends of diagnostic code treated with PPIs

Nationwide cost (1,000,000 KRW) Nationwide utilization (1,000 DDD)

2016 2017 2018 2019 2020 GR in 2020 2016 2017 2018 2019 2020 GR in 2020
GERD 30,871 (59.1%) 34,314 (58.1%) 39,126 (58.0%) 42,508 (56.6%) 49,559 (56.6%) 17% 32,064 (59.8%) 37,916 (59.3%) 44,101 (59.0%) 47,998 (57.8%) 55,020 (57.3%) 15%
Ulcer 9,324 (17.9%) 10,114 (17.1%) 10,628 (15.7%) 11,569 (15.4%) 12,154 (13.9%) 5% 8,557 (15.9%) 9,944 (15.6%) 10,874 (14.5%) 11,701 (14.1%) 12,765 (13.3%) 9%
Gastritis 5,331 (10.2%) 6,508 (11.0%) 7,772 (11.5%) 9,264 (12.3%) 11,522 (13.2%) 24% 5,941 (11.1%) 7,360 (11.5%) 9,035 (12.1%) 10,608 (12.8%) 13,046 (13.6%) 23%
Other 6,699 (12.8%) 8,129 (13.8%) 9,954 (14.8%) 11,747 (15.6%) 14,329 (16.4%) 22% 7,088 (13.2%) 8,700 (13.6%) 10,777 (14.4%) 12,709 (15.3%) 15,182 (15.8%) 19%

GR in 2020 means the Growth Rate in 2020 compared with 2019.

GERD: Gastroesophageal reflux disease

DDD: Defined Daily Dose

Yakhak Hoeji 2021;65:276-83 https://doi.org/10.17480/psk.2021.65.4.276
© 2021 Yakhak Hoeji